Karin A Vallega

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Metabolic Syndrome

Breast Cancer Cells

Fluorescent Probe

Top Venues

Lung Cancer (Auckland, N.Z.)

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhen Chen, Karin A Vallega, Dongsheng Wang, Zihan Quan, Songqing Fan, Qiming Wang, Ticiana A Leal, Suresh R Ramalingam, Shi-Yong Sun
Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer. The Journal of experimental medicine 221 (11) (2024)
Karin A Vallega, Dale B Bosco, Yi Ren, Qing-Xiang Amy Sang
Macrophage-Conditioned Media Promotes Adipocyte Cancer Association, Which in Turn Stimulates Breast Cancer Proliferation and Migration. Biomolecules 12 (12) (2022)
Karin A Vallega, Dale B Bosco, Yi Ren, Qing-Xiang Amy Sang
Macrophage-Conditioned Media Promotes Adipocyte Cancer Association, Which in Turn Stimulates Breast Cancer Proliferation and Migration. Biomolecules 12 (12) (2022)
Karin A Vallega, Dale B Bosco, Yi Ren, Qing-Xiang Amy Sang
Macrophage-Conditioned Media Promotes Adipocyte Cancer Association, Which in Turn Stimulates Breast Cancer Proliferation and Migration. Biomolecules 12 (12) (2022)
Karin A Vallega, Dale B Bosco, Yi Ren, Qing-Xiang Amy Sang
Macrophage-Conditioned Media Promotes Adipocyte Cancer Association, Which in Turn Stimulates Breast Cancer Proliferation and Migration. Biomolecules 12 (12) (2022)
Danlei Yu, Wen Zhao, Karin A Vallega, Shi-Yong Sun
Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling. Lung Cancer (Auckland, N.Z.) 12 (2021)